Intellia Therapeutics Inc. (NTLA) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
16.31
-0.30 (-1.81%)
At close: Sep 26, 2025, 3:59 PM
16.29
-0.12%
After-hours: Sep 26, 2025, 07:50 PM EDT

Intellia Therapeutics Revenue

Intellia Therapeutics reported an annual revenue of $57.88M, reflecting a 59.55% growth. For the quarter ending June 30, 2025, Intellia Therapeutics generated $14.24M in revenue.
Revenue (ttm)
57.88M
Revenue Growth
59.55%
Price / Sales Ratio
19.91
Revenue / Employee
143.62K
Employees
403
Market Cap
1.75B

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2024 57.88M +59.55%
Dec 31, 2023 36.27M -30.40%
Dec 31, 2022 52.12M +57.69%
Dec 31, 2021 33.05M -43.01%
Dec 31, 2020 57.99M +34.55%
Dec 31, 2019 43.1M +41.63%
Dec 31, 2018 30.43M +16.53%
Dec 31, 2017 26.12M +58.49%
Dec 31, 2016 16.48M +172.65%
Dec 31, 2015 6.04M +Infinity%
Dec 31, 2014 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.